An increasing body of research has reported a correlation between cognitive impairment following stroke and alterations in the production of biomarkers, including C-reactive protein (CRP), interleukin 6 (IL-6) and interleukin 10 (IL-10), which are found in blood, urine and other body fluids (Table 1). This evidence concerns the gene CRP and stroke disorder.